Active, Not Recruiting
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
NCT04446117
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Exelixis Clinical Site #4 Tucson, Arizona, United States
- Exelixis Clinical Site #42 Duarte, California, United States
- Exelixis Clinical Site #2 Fullerton, California, United States
- Exelixis Clinical Site #224 La Jolla, California, United States